Ester Fusté

838 total citations
22 papers, 689 citations indexed

About

Ester Fusté is a scholar working on Molecular Medicine, Molecular Biology and Microbiology. According to data from OpenAlex, Ester Fusté has authored 22 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 11 papers in Molecular Biology and 6 papers in Microbiology. Recurrent topics in Ester Fusté's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial biofilms and quorum sensing (7 papers) and Antimicrobial Peptides and Activities (6 papers). Ester Fusté is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial biofilms and quorum sensing (7 papers) and Antimicrobial Peptides and Activities (6 papers). Ester Fusté collaborates with scholars based in Spain, Portugal and Poland. Ester Fusté's co-authors include Teresa Vinuesa, Miguel Viñas, Francesc Rabanal, Josep M. Sierra, Marc Viñas, Eulàlia Sans-Serramitjana, Yolanda Cajal, José Luís Pedraz, Jose Martinez and Alexandra Merlos and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Ester Fusté

21 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Fusté Spain 13 356 295 225 71 68 22 689
Michael D. LaFleur United States 9 665 1.9× 178 0.6× 279 1.2× 52 0.7× 90 1.3× 12 1.2k
Markus Huemer Switzerland 11 352 1.0× 120 0.4× 202 0.9× 26 0.4× 88 1.3× 16 896
Diego-Abelardo Álvarez-Hernández Mexico 10 327 0.9× 219 0.7× 214 1.0× 14 0.2× 49 0.7× 28 713
Karthik Sambanthamoorthy United States 9 617 1.7× 304 1.0× 145 0.6× 33 0.5× 95 1.4× 11 900
Laetitia Charron‐Mazenod Canada 9 753 2.1× 223 0.8× 258 1.1× 94 1.3× 67 1.0× 10 1.0k
Norma Velázquez‐Guadarrama Mexico 16 321 0.9× 122 0.4× 128 0.6× 38 0.5× 108 1.6× 46 826
Hanne Mordhorst Denmark 8 251 0.7× 180 0.6× 176 0.8× 17 0.2× 153 2.3× 14 668
Katarzyna Leszczyńska Poland 18 352 1.0× 319 1.1× 50 0.2× 65 0.9× 110 1.6× 57 959
Seth M. Daly United States 17 379 1.1× 136 0.5× 167 0.7× 21 0.3× 24 0.4× 24 703
Daniela Janek Germany 5 533 1.5× 177 0.6× 77 0.3× 33 0.5× 180 2.6× 5 942

Countries citing papers authored by Ester Fusté

Since Specialization
Citations

This map shows the geographic impact of Ester Fusté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Fusté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Fusté more than expected).

Fields of papers citing papers by Ester Fusté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Fusté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Fusté. The network helps show where Ester Fusté may publish in the future.

Co-authorship network of co-authors of Ester Fusté

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Fusté. A scholar is included among the top collaborators of Ester Fusté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Fusté. Ester Fusté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fusté, Ester, Anamika Sharma, Miguel Viñas, et al.. (2024). 1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization. International Journal of Molecular Sciences. 25(11). 5883–5883. 2 indexed citations
2.
Wessely‐Szponder, Joanna, et al.. (2024). Bioactive Peptides and Other Immunomodulators of Mushroom Origin. Biomedicines. 12(7). 1483–1483. 12 indexed citations
3.
Moro, Giuseppina Lo, José Ramón Paño Pardo, Sergi Hernández, et al.. (2024). Antimicrobial stewardship programs in acute-care hospitals: A multicenter assessment of structure, process, and outcome indicators in Italy and Spain. Journal of Infection and Public Health. 17(7). 102457–102457. 1 indexed citations
4.
Rodríguez, Adrián, et al.. (2023). Care bundle for the prevention of peripheral venous catheter blood stream infections at a secondary care university hospital: Implementation and results. Infection Disease & Health. 28(3). 159–167. 3 indexed citations
5.
Wessely‐Szponder, Joanna, Miguel Viñas, Teresa Vinuesa, et al.. (2023). Native Pig Neutrophil Products: Insights into Their Antimicrobial Activity. Microorganisms. 11(8). 2119–2119. 1 indexed citations
6.
Espinal, Paula, et al.. (2023). Progress towards the clinical use of antimicrobial peptides: challenges and opportunities. Expert Opinion on Biological Therapy. 23(7). 641–650. 5 indexed citations
7.
Azuaje, Carlos, Aída González-Díaz, Juan Pablo Horcajada, et al.. (2022). A Descriptive Analysis of Urinary ESBL-Producing-Escherichia coli in Cerdanya Hospital. Microorganisms. 10(3). 488–488. 5 indexed citations
8.
Armengol, Eva Sanchez, et al.. (2019). <p>Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery</p>. Infection and Drug Resistance. Volume 12. 2031–2038. 27 indexed citations
9.
Merlos, Alexandra, Eulàlia Sans-Serramitjana, Ester Fusté, et al.. (2018). New and old tools to evaluate new antimicrobial peptides. AIMS Microbiology. 4(3). 522–540. 21 indexed citations
10.
Sierra, Josep M., Ester Fusté, Francesc Rabanal, Teresa Vinuesa, & Miguel Viñas. (2017). An overview of antimicrobial peptides and the latest advances in their development. Expert Opinion on Biological Therapy. 17(6). 663–676. 242 indexed citations
11.
Fusté, Ester, et al.. (2017). Identification and characterization of a cell wall porin from <i>Gordonia jacobaea</i>. The Journal of General and Applied Microbiology. 63(5). 266–273. 1 indexed citations
12.
Sans-Serramitjana, Eulàlia, et al.. (2017). Free and Nanoencapsulated Tobramycin: Effects on Planktonic and Biofilm Forms of Pseudomonas. Microorganisms. 5(3). 35–35. 24 indexed citations
13.
Fusté, Ester, et al.. (2016). Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems. Molecules. 21(9). 1223–1223. 57 indexed citations
14.
Fusté, Ester, et al.. (2015). Effects of photodynamic therapy on Enterococcus faecalis biofilms. Lasers in Medical Science. 30(5). 1519–1526. 43 indexed citations
15.
Sans-Serramitjana, Eulàlia, Ester Fusté, Alexandra Merlos, et al.. (2015). Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients. Journal of Cystic Fibrosis. 15(5). 611–618. 64 indexed citations
16.
Segura, C, E Ventura, Elisenda Miró, et al.. (2013). In Vitro Activity of Ceftazidime and Meropenem in Combination with Tobramycin or Ciprofloxacin in A Clone of Multiresistant Pseudomonas Aeruginosa. 3(2). 99–105. 1 indexed citations
17.
Fusté, Ester, et al.. (2013). Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. Journal of Medical Microbiology. 62(9). 1317–1325. 41 indexed citations
18.
Fusté, Ester, et al.. (2012). Comparison of Antibiotic Susceptibility of Old and Current Serratia. Future Microbiology. 7(6). 781–786. 20 indexed citations
19.
Fusté, Ester, et al.. (2011). Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 38(5). 398–402. 55 indexed citations
20.
Fusté, Ester, Lidia Ruíz, Patricia Veiga‐Crespo, et al.. (2009). Role of TolC in Klebsiella oxytoca resistance to antibiotics. Journal of Antimicrobial Chemotherapy. 63(4). 668–674. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. LaFleur Breakdown of academic impact, for papers by Markus Huemer Breakdown of academic impact, for papers by Diego-Abelardo Álvarez-Hernández Breakdown of academic impact, for papers by Karthik Sambanthamoorthy Breakdown of academic impact, for papers by Laetitia Charron‐Mazenod Breakdown of academic impact, for papers by Norma Velázquez‐Guadarrama Breakdown of academic impact, for papers by Hanne Mordhorst Breakdown of academic impact, for papers by Katarzyna Leszczyńska Breakdown of academic impact, for papers by Seth M. Daly Breakdown of academic impact, for papers by Daniela Janek
Rankless by CCL
2026